Pathological findings associated with the updated European Society of Cardiology 2022 guidelines for preoperative cardiac testing: an observational cohort modelling study

Alexandra Stroda*, Eckhard Mauermann, Daniela Ionescu, the MET-REPAIR investigators, Wojciech Szczeklik, Stefan De Hert, Miodrag Filipovic, Beatrice Beck Schimmer, Savino Spadaro, Purificación Matute, Michael T. Ganter, Alexey Ovezov, Sanem C. Turhan, Judith van Waes, Filipa Lagarto, Kassiani Theodoraki, Anil Gupta, Hans Jörg Gillmann, Luca Guzzetti, Katarzyna KotfisJan Larmann, Dan Corneci, Donal J. Buggy, Simon J. Howell, Giovanna Lurati Buse, Johann Kemper, Lena Kohaupt, Jette Witzler, Michael Tuzhikov, Sebastian Roth, René M'Pembele, Theresa Tenge, Cornelia Schultze, Nele Verbarg, Christian Gehrke, Anna Katharina Klemann, Friederike Hagebölling, Svenja Albrecht, Jakob Stroeder, Ann Kristin Schubert, Florian Espeter, Benedikt Russe, Markus A. Weigand, Lars Bergmann, Matthias Unterberg, Petra Bischoff, Raphael Pirzer, Patric Rene Rach, Klaus Ott, Seppe Koopman, Felix Van Lier

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

Background: In 2022, the European Society of Cardiology updated guidelines for preoperative evaluation. The aims of this study were to quantify: (1) the impact of the updated recommendations on the yield of pathological findings compared with the previous guidelines published in 2014; (2) the impact of preoperative B-type natriuretic peptide (NT-proBNP) use for risk estimation on the yield of pathological findings; and (3) the association between 2022 guideline adherence and outcomes. Methods: This was a secondary analysis of MET-REPAIR, an international, prospective observational cohort study (NCT03016936). Primary endpoints were reduced ejection fraction (EF<40%), stress-induced ischaemia, and major adverse cardiovascular events (MACE). The explanatory variables were class of recommendations for transthoracic echocardiography (TTE), stress imaging, and guideline adherence. We conducted second-order Monte Carlo simulations and multivariable regression. Results: In total, 15,529 patients (39% female, median age 72 [inter-quartile range: 67–78] yr) were included. The 2022 update changed the recommendation for preoperative TTE in 39.7% patients, and for preoperative stress imaging in 12.9% patients. The update resulted in missing 1 EF <40% every 3 fewer conducted TTE, and in 4 additional stress imaging per 1 additionally detected ischaemia events. For cardiac stress testing, four more investigations were performed for every 1 additionally detected ischaemia episodes. Use of NT-proBNP did not improve the yield of pathological findings. Multivariable regression analysis failed to find an association between adherence to the updated guidelines and MACE. Conclusions: The 2022 update for preoperative cardiac testing resulted in a relevant increase in tests receiving a stronger recommendation. The updated recommendations for TTE did not improve the yield of pathological cardiac testing.

Original languageEnglish
Pages (from-to)675-684
Number of pages10
JournalBritish Journal of Anaesthesia
Volume132
Issue number4
DOIs
Publication statusPublished - Apr 2024

Bibliographical note

Publisher Copyright: © 2024 British Journal of Anaesthesia

Fingerprint

Dive into the research topics of 'Pathological findings associated with the updated European Society of Cardiology 2022 guidelines for preoperative cardiac testing: an observational cohort modelling study'. Together they form a unique fingerprint.

Cite this